RBI imposed a fine of Rs 3.10 lakh on PAN Emami Cosmed for regulatory violations

Traders Union
All News
Central Banks
RBI's penalty on PAN Emami Cosmed

Highlights

RBI imposed a fine of Rs 3.10 lakh on Emami Cosmed for violation of 'Credit / investment concentration Norms'.
In the statutory inspection as of 31 March 2025, the company was found to have breached the credit exposure limit to single group entities.
RBI clarified that this action is based solely on regulatory non-compliance and is not related to the validity of the company’s transactions or agreements.

This article was translated from the original. Read the original version by our correspondent here.

Inspection, Order, and Basis of Violation

According to the press release issued by the Reserve Bank of India, this penalty has been imposed by exercising powers under Section 58G(1)(b) and Section 58B(5)(aa) of the Reserve Bank of India Act, 1934. The company, previously known as Midkot Investments Private Limited, was found to have failed to comply with certain RBI directions related to 'Credit / investment concentration Norms'.

The RBI conducted a statutory inspection of the company with reference to its financial position as of 31 March 2025. Based on supervisory findings and related correspondence, a show cause notice was issued to the company, asking why a penalty should not be imposed for failure to comply with the directions.

After considering the company’s response and oral submissions made during the personal hearing, the RBI found that the company had breached the regulatory limit set for credit exposure to single group entities. The monetary penalty was imposed on the basis of this established violation.

Regulatory Impact and Next Steps

The central bank clarified that this action is based solely on deficiencies in regulatory compliance and is not intended to pronounce upon the validity of any transaction or agreement entered into by the company or its customers. The RBI also stated that this monetary penalty does not affect its right to take any further action in the future.

This case highlights the importance of compliance with risk concentration limits in the non-banking financial sector. Regulatory oversight of excessive credit exposure to single groups is considered crucial for risk management and maintaining balanced exposure in the financial system.

In our previous report, we covered the compounding order received by Apothecon Pharmaceuticals Private Limited from the RBI for FEMA violations related to foreign investment compliance. This included procedural violations such as delays in reporting Form ARF/FCGPR/FLA Return and share allotment without prior approval. After settlement of these violations and fulfillment of prescribed conditions, the regulatory impact of closure of further investigation/action was highlighted.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.